Crossmark

Diagnostic approaches for pericardial effusions

Crossref DOI link: https://doi.org/10.1007/s00059-017-4661-3

Published Online: 2017-12-15

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rigopoulos, A. G.

Ali, M.

Sakellaropoulos, S.

Matiakis, M.

Teren, M.

Mammadov, M.

Ahmadzada, B.

Noutsias, M. https://orcid.org/0000-0002-9066-5262
License Information

Text and Data Mining valid from 2017-12-15
More Information

Article History

Received: 24 November 2017

Accepted: 24 November 2017

First Online: 15 December 2017

Conflict of interest

: A.G. Rigopoulos, M. Ali, S. Sakellaropoulos, M. Matiakis, M. Teren, M. Mammadov, and B. Ahmadzada declare that they have no competing interests. M. Noutsias has received grants by the Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich Transregio 19 “Inflammatory Cardiomyopathy” (SFB TR19) (TP B2), and by the University Hospital Giessen and Marburg Foundation Grant “T cell functionality” (UKGM 10/2009). M. Noutsias has been consultant to the IKDT (Institute for Cardiac Diagnosis and Therapy GmbH, Berlin) 06/2004–06/2008, and has received honoraria for presentations and/or participated in advisory boards from AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, Miltenyi Biotech, Novartis, Pfizer, and Zoll.